(Q34330977)

1 August 2017

1 reference

title

Pharmacological treatments of cerebellar ataxia (English)

1 reference

1 August 2017

1 reference

Masafumi Ogawa

1

1 reference

1 August 2017

publication date

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

107-111

1 reference

https://scigraph.springernature.com/pub.10.1080/147342204100032331

1 August 2017

exact match

0 references

cites work

Emerging Treatments: Replacement Therapy with Choline or Lecithin in Neurological Diseases

1 reference

12 December 2020

Tetrahydrobiopterin double-blind, crossover trial in Machado-Joseph disease

1 reference

12 December 2020

Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration

1 reference

12 December 2020

Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy

1 reference

12 December 2020

An approach using lecithin treatment for olivopontocerebellar atrophies

1 reference

12 December 2020

Double-blind, triple-crossover trial of low doses of oral physostigmine in inherited ataxias.

1 reference

12 December 2020

Lecithin in hereditary ataxia

1 reference

12 December 2020

d-Cycloserine for the treatment of ataxia in spinocerebellar degeneration

1 reference

12 December 2020

Action of physostigmine on inherited ataxias

1 reference

12 December 2020

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel

1 reference

12 December 2020

Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor

1 reference

12 December 2020

High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2

1 reference

12 December 2020

Use of buspirone for treatment of cerebellar ataxia. An open-label study

1 reference

12 December 2020

Analysis of fast single-joint and multijoint movements in cerebellar cortical atrophy: failure of L-hydroxytryptophan to improve cerebellar ataxia.

1 reference

12 December 2020

A treatment for ataxia

1 reference

12 December 2020

Physostigmine in familial ataxias

1 reference

12 December 2020

Effect of sulfamethoxazole and trimethoprim on neurologic dysfunction in a patient with Joseph's disease

1 reference

12 December 2020

Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia

1 reference

12 December 2020

Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases

1 reference

12 December 2020

Effects of TRH on ballistic wrist movements in cerebellar cortical atrophy: improvement of two genuine deficiencies but not of the major one

1 reference

12 December 2020

The use of choline chloride in ataxic disorders

1 reference

12 December 2020

Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases

1 reference

12 December 2020

Lack of efficacy of phosphatidylcholine in ataxias

1 reference

12 December 2020

A six-month phosphatidylcholine trial in Friedreich's ataxia

1 reference

12 December 2020

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

12 December 2020

Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.

1 reference

12 December 2020

Glutamate dehydrogenase deficiency in three patients with spinocerebellar ataxia: a new enzymatic defect?

1 reference

12 December 2020

Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study

1 reference

12 December 2020

Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study

1 reference

12 December 2020

Choline chloride in the treatment of cerebellar and spinocerebellar ataxia

1 reference

12 December 2020

Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy

1 reference

12 December 2020

Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin

1 reference

12 December 2020

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

1 reference

12 December 2020

Hereditary paroxysmal ataxia: Response to acetazolamide

1 reference

12 December 2020

The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice

1 reference

12 December 2020

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease

1 reference

12 December 2020

Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing

1 reference

12 December 2020

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry

1 reference

12 December 2020

Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study.

1 reference

12 December 2020

Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy.

1 reference

12 December 2020

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

1 reference

12 December 2020

Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.

1 reference

12 December 2020

Oral choline in cerebellar ataxia

1 reference

12 December 2020

Phencyclidine: an overview

1 reference

12 December 2020

The stereo-specific effect of D-serine ethylester and the D-cycloserine in ataxic mutant mice.

1 reference

12 December 2020

Brain amino acid reductions in one family with chromosome 6p?linked dominantly inherited olivopontocerebellar atrophy

1 reference

12 December 2020

10.1080/147342204100032331

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1037848046

0 references

1 reference